News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search More than one hundred patients with locally advanced and borderline resectable cancer 23/08/2024 A clinical trial has led to approval of the first drug for advanced fatty liver disease 26/03/2024 New treatment based on nanoparticles for chronic liver disease 14/11/2023 Vall d'Hebron hosts a meeting on advances in pertussis 09/10/2023 Vall d’Hebron acull una sessió sobre els assaigs clínics en fetge gras no alcohòlicl 24/05/2023 COVID-19 vaccine generates memory immune cells in lungs 12/04/2023 A Vall d'Hebron study finds a mechanism used by SARS-CoV-2 related to its transmissibility 03/03/2023 Two Vall d’Hebron research projects get grants from the City Council and the “La Caixa 02/03/2023 Collaborative trial platforms, key in the NASH research 14/11/2022 A study shows that 40% of patients with monkeypox have complications requiring treatment 10/08/2022 Vall d’Hebron hosted IMI-2 EU-PEARL work meeting about platforms for clinical trials 17/05/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 RESPONSE, a global phase III clinical trial for primary biliary cholangitis 03/02/2022 Vall d'Hebron, a reference in care and research in enterovirus infection 29/12/2021 Published the results of the Vall d’Hebron study, which shows that minors are low transmitters of SARS-CoV-2 15/03/2021 Vall d’Hebron describes two cases of fetuses with edema in pregnant women with COVID-19 17/08/2020 A Vall d’Hebron study shows that 70% of residents and 56% of staff infected with SARS-CoV-2 in nursing homes are asymptomatic 01/07/2020